MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. The company was founded by Ernst Ludwig Winnacker and Horst Domdey in June 1994 and is headquartered in Martinsried, Germany.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Medigene AG?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Medigene AG market cap is $1.49M.
What is the 52-week high for Medigene AG?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Medigene AG 52 week high is $1.30 as of September 06, 2025.
What is the 52-week low for Medigene AG?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Medigene AG 52 week low is $0.10 as of September 06, 2025.
What is Medigene AG stock price today?
Medigene AG stock price today is $0.10.
What was Medigene AG stock price yesterday?
Medigene AG stock price yesterday was $2.59.
What is the PE ratio of Medigene AG?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Medigene AG’s P/E ratio is -0.08.
What is the Price-to-Book ratio of Medigene AG?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Medigene AG P/B ratio is 0.0699.
What is the 50-day moving average of Medigene AG?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Medigene AG 50-day moving average is $0.10.
